{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:58:56Z","timestamp":1793145536398,"version":"4.5.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Experimental studies suggest that excess serum free fatty acid (FFA) levels result in impaired glucose metabolism. This study investigated the relationship between changes in serum FFA levels after glucose intake and type 2 diabetes risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>This observational study included 6,800 individuals without diabetes who underwent a 75-g oral glucose tolerance test. Serum FFA levels were measured before and 30 and 60 min after glucose intake. The percentages of changes in serum FFA levels from 0 to 30 and from 30 to 60 min were compared, and a low rate of change in FFA levels was determined using the receiver operating characteristic curve analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Over a mean 5.3-year follow-up period, 485 participants developed type 2 diabetes. After adjusting for plasma glucose levels and indices of insulin resistance and \u03b2-cell function, low rates of change in FFA levels at 0\u201330 min (adjusted odds ratio [aOR] 1.91; 95% CI 1.54\u20132.37) and 30\u201360 min (aOR 1.48; 95% CI 1.15\u20131.90) were associated with the incidence of type 2 diabetes. Stratified analysis revealed that the low rate of change in FFA levels at 30\u201360 min (aOR 1.97; 95% CI 1.05\u20133.69) was associated with the incidence of type 2 diabetes even in participants with normal fasting glucose levels or glucose tolerance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Changes in serum FFA levels within the 1st h after glucose intake could be a primary predictor of type 2 diabetes. This change may occur prior to the onset of impaired glucose metabolism.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc21-2554","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T20:24:43Z","timestamp":1660076683000},"page":"2309-2315","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":10,"title":["Early-Phase Changes in Serum Free Fatty Acid Levels After Glucose Intake Are Associated With Type 2 Diabetes Incidence: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases"],"prefix":"10.2337","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-7737","authenticated-orcid":false,"given":"Nobuo","family":"Sasaki","sequence":"first","affiliation":[{"name":"1Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Maeda","sequence":"additional","affiliation":[{"name":"1Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Ozono","sequence":"additional","affiliation":[{"name":"2Department of General Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"4Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-3672","authenticated-orcid":false,"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[{"name":"5Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"2022092319004903700_B1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/db16-1167","article-title":"Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study","volume":"66","author":"Gastaldelli","year":"2017","journal-title":"Diabetes"},{"key":"2022092319004903700_B2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/dc18-1178","article-title":"Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes","volume":"42","author":"Kim","year":"2019","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00125-003-1301-7","article-title":"Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men","volume":"47","author":"Leung","year":"2004","journal-title":"Diabetologia"},{"key":"2022092319004903700_B4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/diabetes.54.6.1640","article-title":"Dose-response effect of elevated plasma free fatty acid on insulin signaling","volume":"54","author":"Belfort","year":"2005","journal-title":"Diabetes"},{"key":"2022092319004903700_B5","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/BF00422371","article-title":"A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM","volume":"38","author":"Paolisso","year":"1995","journal-title":"Diabetologia"},{"key":"2022092319004903700_B6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s001250050793","article-title":"The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study","volume":"40","author":"Charles","year":"1997","journal-title":"Diabetologia"},{"key":"2022092319004903700_B7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.27.1.77","article-title":"Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study","volume":"27","author":"Pankow","year":"2004","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1464-5491.1999.00184.x","article-title":"Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome","volume":"16","author":"Byrne","year":"1999","journal-title":"Diabet Med"},{"key":"2022092319004903700_B9","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.2147\/DMSO.S302681","article-title":"Associations between serum free fatty acid levels and incident diabetes in a 3-year cohort study","volume":"14","author":"Li","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2022092319004903700_B10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00125-010-1657-4","article-title":"Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose","volume":"53","author":"Il\u2019yasova","year":"2010","journal-title":"Diabetologia"},{"key":"2022092319004903700_B11","first-page":"E278","article-title":"Effect of short-term fasting on lipid kinetics in lean and obese women","volume":"276","author":"Horowitz","year":"1999","journal-title":"Am J Physiol"},{"key":"2022092319004903700_B12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"2022092319004903700_B13","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"2022092319004903700_B14","doi-asserted-by":"crossref","first-page":"e001500","DOI":"10.1136\/bmjdrc-2020-001500","article-title":"Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes","volume":"8","author":"Sasaki","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022092319004903700_B15","doi-asserted-by":"crossref","first-page":"108780","DOI":"10.1016\/j.diabres.2021.108780","article-title":"Diversity in the risk of type 2 diabetes associated with age, sex, and 1-h post-load plasma glucose levels in the Japanese population with prediabetes","volume":"175","author":"Sasaki","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2022092319004903700_B16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00592-018-01285-3","article-title":"Relation of the degree of obesity in childhood to adipose tissue insulin resistance","volume":"56","author":"Hagman","year":"2019","journal-title":"Acta Diabetol"},{"key":"2022092319004903700_B18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ijo.2017.110","article-title":"Methods for quantifying adipose tissue insulin resistance in overweight\/obese humans","volume":"41","author":"Ter Horst","year":"2017","journal-title":"Int J Obes"},{"key":"2022092319004903700_B19","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.2337\/dc10-0646","article-title":"Reduced time points to calculate the composite index","volume":"33","author":"DeFronzo","year":"2010","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diacare.23.9.1440","article-title":"Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"2022092319004903700_B22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version","volume":"20","author":"Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"2022092319004903700_B23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","article-title":"Japanese guideline for the management of hyperuricemia and gout: second edition","volume":"30","author":"Yamanaka","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2022092319004903700_B24","first-page":"5","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Summary of recommendation statements","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2022092319004903700_B25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","article-title":"Free fatty acids and pathogenesis of type 2 diabetes mellitus","volume":"11","author":"Bergman","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2022092319004903700_B26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","article-title":"Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach","volume":"89","author":"Bays","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092319004903700_B27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI115005","article-title":"Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man","volume":"87","author":"Groop","year":"1991","journal-title":"J Clin Invest"},{"key":"2022092319004903700_B28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcn\/59.2.350","article-title":"Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study","volume":"59","author":"Astrup","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"2022092319004903700_B29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic flexibility in health and disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metab"},{"key":"2022092319004903700_B30","first-page":"e146000","article-title":"Metabolic flexibility across the spectrum of glycemic regulation in youth","volume":"6","author":"Bacha","year":"2021","journal-title":"JCI Insight"},{"key":"2022092319004903700_B31","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.2337\/diabetes.51.2007.S109","article-title":"Phasic insulin release and metabolic regulation in type 2 diabetes","volume":"51","author":"Del Prato","year":"2002","journal-title":"Diabetes"},{"key":"2022092319004903700_B32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118846","article-title":"Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs","volume":"98","author":"Rebrin","year":"1996","journal-title":"J Clin Invest"},{"key":"2022092319004903700_B33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diab.46.2.187","article-title":"The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog","volume":"46","author":"Sindelar","year":"1997","journal-title":"Diabetes"},{"key":"2022092319004903700_B34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022092319004903700_B35","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/db12-1122","article-title":"Relation between serum free fatty acids and adiposity, insulin resistance, and cardiovascular risk factors from adolescence to adulthood","volume":"62","author":"Frohnert","year":"2013","journal-title":"Diabetes"},{"key":"2022092319004903700_B36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diabetes.49.3.399","article-title":"Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes","volume":"49","author":"Carpentier","year":"2000","journal-title":"Diabetes"},{"key":"2022092319004903700_B37","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1111\/cob.12496","article-title":"Association of obesity with serum free fatty acid levels in individuals at different stages of prediabetes","volume":"12","author":"Sasaki","year":"2022","journal-title":"Clin Obes"},{"key":"2022092319004903700_B38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabres.2018.09.011","article-title":"Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: the CARRS and NHANES studies","volume":"146","author":"Gujral","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2022092319004903700_B39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc12-1235","article-title":"Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis","volume":"36","author":"Kodama","year":"2013","journal-title":"Diabetes Care"},{"key":"2022092319004903700_B40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","author":"Ogihara","year":"2008","journal-title":"Hypertension"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/10\/2309\/688769\/dc212554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/45\/10\/2309\/688769\/dc212554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T19:12:32Z","timestamp":1663960352000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/45\/10\/2309\/147410\/Early-Phase-Changes-in-Serum-Free-Fatty-Acid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,8,9]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc21-2554","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}